Remdesivir is a delayed translocation inhibitor of SARS CoV-2 replication. Bravo et al
Published: 21 January 2021| Version 1 | DOI: 10.17632/ry9rk6tmcn.1
Contributor:
David Taylor
Description
Supplemental Information for Remdesivir is a delayed translocation inhibitor of SARS CoV-2 replication by Bravo et al
Files
Institutions
University of Texas at Austin
Categories
Cryo-Transmission Electron Microscopy